My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
ALLERGAN
Clerk
>
Contracts / Agreements
>
A
>
ALLERGAN
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/12/2023 3:20:14 PM
Creation date
4/12/2023 3:19:29 PM
Metadata
Fields
Template:
Contracts
Company Name
ALLERGAN
Contract #
A-2023-060-05
Agency
City Attorney's Office
Council Approval Date
4/4/2023
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
12
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
DocuSign Envelope ID: B15AAEBD-74AB-4EFF-B97F-0776E33BOD86 <br />c) The California Department of Health Care Services ("DHCS") may add to this list (but <br />not delete from it) by designating additional High Impact Abatement Activities. DHCS <br />will make reasonable efforts to consult with stakeholders, including the CA Participating <br />Subdivisions, before adding additional High Impact Abatement Activities to this list. <br />d) For the avoidance of doubt, and subject to the requirements of the Allergan Settlement <br />Agreement and applicable law, CA Participating Subdivisions may form agreements or <br />ventures, or.otherwise work in collaboration with, federal, state, local, tribal or private <br />sector entities in pursuing Opioid Remediation activities funde.41rorn the CA Abatement <br />Accounts Fund. Further, provided that all CA Abatement Accounts Funds are used for <br />Opioid Remediation consistent with the Allergan Settlement Agreement and this CA <br />Allergan Allocation Agreement, a county and any cities or towns within the county may <br />agree to reallocate their respective shares of the CA Abatement Accounts Funds among <br />themselves, provided that any direct distribution may only be to a CA Participating <br />Subdivision and any CA Participating Subdivision must agree to their share being <br />reallocated. <br />iii. CA Abatement Accounts I7und Oversight <br />a) Pursuant to Section 5 below, CA Participating Subdivisions receiving settlement funds <br />must prepare and file reports annually regarding the use of those funds. DHCS may <br />regularly review the reports prepared by CA Participating Subdivisions about the use of <br />CA Abatement Accounts Funds for compliance with the Allergan Settlement <br />Agreement and this CA Allergan Allocation Agreement. <br />b) If DHCS determines that a CA Participating Subdivision's use of CA Abatement <br />Accounts Funds is inconsistent with the Allergan Settlement Agreement or this CA <br />Allergan Allocation Agreement, whether through review of reports or information from <br />any other sources, DHCS shall send a request to meet and confer with the CA <br />Participating Subdivision. The parties shall meet and confer in an effort to resolve the <br />concern. <br />c) If the parties are unable to reach a resolution, DHCS may conduct an audit of the <br />Subdivision's use of the CA Abatement Accounts Funds within one year of the request to <br />meet and Confer, unless the parties mutually agree in writing to eytend the meet and <br />confer time frame. <br />d) If the concern still cannot be resolved, the State may bring a motion or action in the court' <br />where the State has filed its Consent Judgment to resolve the concern or otherwise <br />� q <br />5 p <br />
The URL can be used to link to this page
Your browser does not support the video tag.